Stocks and Investing Stocks and Investing
Wed, December 7, 2022
Tue, December 6, 2022

Terence Flynn Maintained (UTHR) at Buy with Increased Target to $330 on, Dec 6th, 2022


Published on 2024-10-28 00:27:33 - WOPRAI, Terence Flynn
  Print publication without navigation


Terence Flynn of Morgan Stanley, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Increased Target from $322 to $330 on, Dec 6th, 2022.

Terence has made no other calls on UTHR in the last 4 months.



There are 4 other peers that have a rating on UTHR. Out of the 4 peers that are also analyzing UTHR, 0 agree with Terence's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Terence


  • Chris Shibutani of "Goldman Sachs" Initiated at Strong Sell and Held Target at $230 on, Monday, December 5th, 2022
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $375 on, Thursday, November 3rd, 2022
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $265 on, Thursday, November 3rd, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $300 on, Thursday, November 3rd, 2022
Contributing Sources